Wednesday, October 4, 2023
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor
Department of Ophthalmology
University of Munich
Munich, Germany
Professor and Chair
Ophthalmology Department
Bicêtre Hospital
Paris Saclay University
Paris, France
Professor and Chair
Department of Hematology and Medical Oncology
Emory University
Atlanta, Georgia, United States
The opinions expressed are those of Dr Lonial and do not necessarily reflect the views of Emory University or Emory Healthcare.
Dr Lonial's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Professor
Hospital Saint-Antoine and
Sorbonne University
Paris, France
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This educational activity is intended for an international audience of non-US hematology and oncology specialists and ophthalmologists.
The goal of this activity is to educate physicians and ophthalmologists on the potential eye toxicities associated with anticancer drugs used to treat hematological malignancies, and their practical mitigation and management.
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor
Department of Ophthalmology
University of Munich
Munich, Germany
Professor and Chair
Ophthalmology Department
Bicêtre Hospital
Paris Saclay University
Paris, France
Professor and Chair
Department of Hematology and Medical Oncology
Emory University
Atlanta, Georgia, United States
The opinions expressed are those of Dr Lonial and do not necessarily reflect the views of Emory University or Emory Healthcare.
Dr Lonial's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Professor
Hospital Saint-Antoine and
Sorbonne University
Paris, France
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 4/21/2021
Valid for credit through: 4/21/2022, 11:59 PM EST
processing....
The goal of this activity is to educate physicians and ophthalmologists on the potential eye toxicities associated with anticancer drugs used to treat hematological malignancies, and their practical mitigation and management.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
